Furthermore, animal experiments have also revealed that the PRMT3 inhibitor SGC707 could significantly reduce the embryo uptake rate in a mouse model prone to miscarriage, which demonstrates that the PRMT3/ADMA/NO pathway could be a potential target for the treatment of miscarriage. This evidence concerns the gene PRMT3 and Miscarriage.